Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $71 | $88 | $54 | $98 |
| Short-Term Investments | $157 | $183 | $356 | $291 |
| Receivables | $73 | $26 | $8 | $0 |
| Inventory | $15 | $13 | $8 | $0 |
| Other Curr. Assets | $20 | $20 | $12 | $14 |
| Total Curr. Assets | $336 | $330 | $437 | $403 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $9 | $6 | $7 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $13 | $11 | $12 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $349 | $341 | $449 | $408 |
| Liabilities | – | – | – | – |
| Payables | $14 | $12 | $9 | $7 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $66 | $34 | $28 | $26 |
| Total Curr. Liab. | $81 | $47 | $38 | $33 |
| LT Debt | $110 | $205 | $202 | $77 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $0 | $0 |
| Total NC Liab. | $110 | $206 | $202 | $77 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $5 | $5 |
| Total Liabilities | $191 | $253 | $240 | $110 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,122 | -$982 | -$720 | -$408 |
| AOCI | -$0 | $0 | -$1 | -$0 |
| Other Equity | $1,279 | $1,071 | $930 | $706 |
| Total Equity | $158 | $89 | $210 | $298 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $349 | $341 | $449 | $408 |
| Net Debt | $39 | $118 | $150 | -$20 |